Validating Biobehavioral Technologies for Use in Clinical Psychiatry

The last decade has witnessed the development of sophisticated biobehavioral and genetic, ambulatory, and other measures that promise unprecedented insight into psychiatric disorders. As yet, clinical sciences have struggled with implementing these objective measures and they have yet to move beyond...

Full description

Bibliographic Details
Main Authors: Alex S. Cohen, Christopher R. Cox, Raymond P. Tucker, Kyle R. Mitchell, Elana K. Schwartz, Thanh P. Le, Peter W. Foltz, Terje B. Holmlund, Brita Elvevåg
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.503323/full
_version_ 1830132449561018368
author Alex S. Cohen
Alex S. Cohen
Christopher R. Cox
Raymond P. Tucker
Kyle R. Mitchell
Elana K. Schwartz
Thanh P. Le
Peter W. Foltz
Terje B. Holmlund
Brita Elvevåg
Brita Elvevåg
author_facet Alex S. Cohen
Alex S. Cohen
Christopher R. Cox
Raymond P. Tucker
Kyle R. Mitchell
Elana K. Schwartz
Thanh P. Le
Peter W. Foltz
Terje B. Holmlund
Brita Elvevåg
Brita Elvevåg
author_sort Alex S. Cohen
collection DOAJ
description The last decade has witnessed the development of sophisticated biobehavioral and genetic, ambulatory, and other measures that promise unprecedented insight into psychiatric disorders. As yet, clinical sciences have struggled with implementing these objective measures and they have yet to move beyond “proof of concept.” In part, this struggle reflects a traditional, and conceptually flawed, application of traditional psychometrics (i.e., reliability and validity) for evaluating them. This paper focuses on “resolution,” concerning the degree to which changes in a signal can be detected and quantified, which is central to measurement evaluation in informatics, engineering, computational and biomedical sciences. We define and discuss resolution in terms of traditional reliability and validity evaluation for psychiatric measures, then highlight its importance in a study using acoustic features to predict self-injurious thoughts/behaviors (SITB). This study involved tracking natural language and self-reported symptoms in 124 psychiatric patients: (a) over 5–14 recording sessions, collected using a smart phone application, and (b) during a clinical interview. Importantly, the scope of these measures varied as a function of time (minutes, weeks) and spatial setting (i.e., smart phone vs. interview). Regarding reliability, acoustic features were temporally unstable until we specified the level of temporal/spatial resolution. Regarding validity, accuracy based on machine learning of acoustic features predicting SITB varied as a function of resolution. High accuracy was achieved (i.e., ~87%), but only when the acoustic and SITB measures were “temporally-matched” in resolution was the model generalizable to new data. Unlocking the potential of biobehavioral technologies for clinical psychiatry will require careful consideration of resolution.
first_indexed 2024-12-17T06:35:32Z
format Article
id doaj.art-5c963f38c097488d87019feb05bb2fbe
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-17T06:35:32Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-5c963f38c097488d87019feb05bb2fbe2022-12-21T22:00:01ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-06-011210.3389/fpsyt.2021.503323503323Validating Biobehavioral Technologies for Use in Clinical PsychiatryAlex S. Cohen0Alex S. Cohen1Christopher R. Cox2Raymond P. Tucker3Kyle R. Mitchell4Elana K. Schwartz5Thanh P. Le6Peter W. Foltz7Terje B. Holmlund8Brita Elvevåg9Brita Elvevåg10Department of Psychology, Louisiana State University, Baton Rouge, LA, United StatesCenter for Computation and Technology Louisiana State University, Baton Rouge, LA, United StatesDepartment of Psychology, Louisiana State University, Baton Rouge, LA, United StatesDepartment of Psychology, Louisiana State University, Baton Rouge, LA, United StatesDepartment of Psychology, Louisiana State University, Baton Rouge, LA, United StatesDepartment of Psychology, Louisiana State University, Baton Rouge, LA, United StatesDepartment of Psychology, Louisiana State University, Baton Rouge, LA, United StatesDepartment of Psychology, University of Colorado, Boulder, CO, United StatesDepartment of Clinical Medicine, University of Tromsø—The Arctic University of Norway, Tromsø, NorwayDepartment of Clinical Medicine, University of Tromsø—The Arctic University of Norway, Tromsø, NorwayThe Norwegian Center for eHealth Research, University Hospital of North Norway, Tromsø, NorwayThe last decade has witnessed the development of sophisticated biobehavioral and genetic, ambulatory, and other measures that promise unprecedented insight into psychiatric disorders. As yet, clinical sciences have struggled with implementing these objective measures and they have yet to move beyond “proof of concept.” In part, this struggle reflects a traditional, and conceptually flawed, application of traditional psychometrics (i.e., reliability and validity) for evaluating them. This paper focuses on “resolution,” concerning the degree to which changes in a signal can be detected and quantified, which is central to measurement evaluation in informatics, engineering, computational and biomedical sciences. We define and discuss resolution in terms of traditional reliability and validity evaluation for psychiatric measures, then highlight its importance in a study using acoustic features to predict self-injurious thoughts/behaviors (SITB). This study involved tracking natural language and self-reported symptoms in 124 psychiatric patients: (a) over 5–14 recording sessions, collected using a smart phone application, and (b) during a clinical interview. Importantly, the scope of these measures varied as a function of time (minutes, weeks) and spatial setting (i.e., smart phone vs. interview). Regarding reliability, acoustic features were temporally unstable until we specified the level of temporal/spatial resolution. Regarding validity, accuracy based on machine learning of acoustic features predicting SITB varied as a function of resolution. High accuracy was achieved (i.e., ~87%), but only when the acoustic and SITB measures were “temporally-matched” in resolution was the model generalizable to new data. Unlocking the potential of biobehavioral technologies for clinical psychiatry will require careful consideration of resolution.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.503323/fulldigital phenotypingserious mental illnessclinical sciencepsychiatric illnessbiobehavioralpsychometrics
spellingShingle Alex S. Cohen
Alex S. Cohen
Christopher R. Cox
Raymond P. Tucker
Kyle R. Mitchell
Elana K. Schwartz
Thanh P. Le
Peter W. Foltz
Terje B. Holmlund
Brita Elvevåg
Brita Elvevåg
Validating Biobehavioral Technologies for Use in Clinical Psychiatry
Frontiers in Psychiatry
digital phenotyping
serious mental illness
clinical science
psychiatric illness
biobehavioral
psychometrics
title Validating Biobehavioral Technologies for Use in Clinical Psychiatry
title_full Validating Biobehavioral Technologies for Use in Clinical Psychiatry
title_fullStr Validating Biobehavioral Technologies for Use in Clinical Psychiatry
title_full_unstemmed Validating Biobehavioral Technologies for Use in Clinical Psychiatry
title_short Validating Biobehavioral Technologies for Use in Clinical Psychiatry
title_sort validating biobehavioral technologies for use in clinical psychiatry
topic digital phenotyping
serious mental illness
clinical science
psychiatric illness
biobehavioral
psychometrics
url https://www.frontiersin.org/articles/10.3389/fpsyt.2021.503323/full
work_keys_str_mv AT alexscohen validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT alexscohen validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT christopherrcox validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT raymondptucker validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT kylermitchell validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT elanakschwartz validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT thanhple validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT peterwfoltz validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT terjebholmlund validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT britaelvevag validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry
AT britaelvevag validatingbiobehavioraltechnologiesforuseinclinicalpsychiatry